$CHCO
City Holding Co Stock $chco

$chco Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000072685420000082 Filed on May 07, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$48.22M	$48.93M
YoY Change	-1.46%	29.99%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.325M	$1.209M
YoY Change	9.59%	-4.8%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$7.801M	$8.867M
YoY Change	-12.02%	77.45%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$36.32M	$27.64M
YoY Change	31.43%	24.45%
Income Tax	$7.322M	$5.810M
% Of Pretax Income	20.16%	21.02%
Net Earnings	$29.00M	$21.62M
YoY Change	34.12%	22.72%
Net Earnings / Revenue	60.14%	44.18%
Basic Earnings Per Share	$1.79	$1.31
Diluted Earnings Per Share	$1.78	$1.30
COMMON SHARES
Basic Shares Outstanding	16.08M shares	16.41M shares
Diluted Shares Outstanding	16.10M shares	16.43M shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.072B	$980.4M
YoY Change	9.3%	30.06%
Cash & Equivalents	$110.6M	$143.9M
Short-Term Investments	$960.9M	$836.6M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$78.95M	$78.75M
YoY Change	0.26%	7.99%
Goodwill		$109.0M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.200M	$12.70M
YoY Change	-82.68%	-12.41%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$5.088B	$4.918B
YoY Change	3.47%	17.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$224.2M	$194.7M
YoY Change	15.15%	-0.36%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$224.2M	$194.7M
YoY Change	15.15%	-0.36%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$4.100M
YoY Change	-100.0%	-75.15%
Other Long-Term Liabilities	$117.0M	$56.60M
YoY Change	106.71%	14.81%
Total Long-Term Liabilities	$117.0M	$60.70M
YoY Change	92.75%	-7.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$224.2M	$194.7M
Total Long-Term Liabilities	$117.0M	$60.70M
Total Liabilities	$4.403B	$4.298B
YoY Change	2.44%	15.92%
SHAREHOLDERS EQUITY
Retained Earnings	$556.7M	$498.8M
YoY Change	11.6%	9.0%
Common Stock	$217.7M	$217.8M
YoY Change	-0.05%	15.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$116.7M	$91.59M
YoY Change	27.38%	-33.35%
Treasury Stock Shares	2.907M shares	2.564M shares
Shareholders Equity	$685.2M	$619.2M
YoY Change
Total Liabilities & Shareholders Equity	$5.088B	$4.918B
YoY Change	3.47%	17.09%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	$29.00M	$21.62M
YoY Change	34.12%	22.72%
Depreciation, Depletion And Amortization	$1.325M	$1.209M
YoY Change	9.59%	-4.8%
Cash From Operating Activities	$23.13M	$20.06M
YoY Change	15.28%	65.93%
INVESTING ACTIVITIES
Capital Expenditures	$3.329M	$1.576M
YoY Change	111.23%	0.96%
Acquisitions
YoY Change
Other Investing Activities	-$22.20M	$14.50M
YoY Change	-253.1%	-163.6%
Cash From Investing Activities	-$25.58M	$12.93M
YoY Change	-297.75%	-153.0%
FINANCING ACTIVITIES
Cash Dividend Paid	$9.293M	$8.775M
YoY Change	5.9%	22.11%
Common Stock Issuance & Retirement, Net	$12.97M	$4.089M
YoY Change	217.22%	-70.79%
Debt Paid & Issued, Net	$4.124M	$0.00
YoY Change
Cash From Financing Activities	-$27.06M	-$12.14M
YoY Change	122.97%	-122.65%
NET CHANGE
Cash From Operating Activities	$23.13M	$20.06M
Cash From Investing Activities	-$25.58M	$12.93M
Cash From Financing Activities	-$27.06M	-$12.14M
Net Change In Cash	-$29.51M	$20.86M
YoY Change	-241.46%	-49.46%
FREE CASH FLOW
Cash From Operating Activities	$23.13M	$20.06M
Capital Expenditures	$3.329M	$1.576M
Free Cash Flow	$19.80M	$18.49M
YoY Change	7.1%	75.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000726854
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	50598000	USD
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	25
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	25
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19047548	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19047548	shares
CY2020Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	2907168	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2744109	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	600764000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	21619000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8631000	USD
CY2019Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8739000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	803000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	252000	USD
CY2019Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4089000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	619241000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	657983000	USD
CY2020Q1	chco	New Accounting Pronouncement Effect Of Adoption Quantification NewAccountingPronouncementEffectOfAdoptionQuantification	-2335000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	29000000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	21620000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	9200000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1009000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	122000	USD
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	12971000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	685228000	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.57
CY2019Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.53
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2650	shares
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5638	shares
CY2020Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	181899	shares
CY2019Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	54740	shares
CY2020Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.57
CY2019Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.53
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2650	shares
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5638	shares
CY2020Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	181899	shares
CY2019Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	54740	shares
CY2019Q4	chco	Percent Of Average Daily Trading Volume PercentOfAverageDailyTradingVolume	0.002
CY2019Q4	chco	Non Governmental Issues Exceeding10 Shareholders Equity Threshold NonGovernmentalIssuesExceeding10ShareholdersEquityThreshold	0	USD
CY2019Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Additional Credit Losses OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsAdditionalCreditLosses	0	USD
CY2019Q1	chco	Threshold Periodfor Discontinuanceof Interest Accrual ThresholdPeriodforDiscontinuanceofInterestAccrual	P90D
CY2019Q4	us-gaap	Financing Receivable Threshold Period Past Due FinancingReceivableThresholdPeriodPastDue	P30D
CY2019Q1	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	100000	USD
CY2019Q1	chco	Financing Receivables Impaired Troubled Debt Restructuring Provision For Credit Losses FinancingReceivablesImpairedTroubledDebtRestructuringProvisionForCreditLosses	100000	USD
CY2019Q1	us-gaap	Financing Receivables Impaired Troubled Debt Restructuring Write Down FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown	100000	USD
CY2020Q1	chco	Combined Federal And State Income Tax Rate CombinedFederalAndStateIncomeTaxRate	0.23
CY2019Q1	chco	Combined Federal And State Income Tax Rate CombinedFederalAndStateIncomeTaxRate	0.23
CY2019Q1	chco	Combined Federal And State Income Tax Rate CombinedFederalAndStateIncomeTaxRate	0.23
CY2019Q1	us-gaap	Derivative Credit Risk Valuation Adjustment Derivative Assets DerivativeCreditRiskValuationAdjustmentDerivativeAssets	0	USD
CY2019Q4	us-gaap	Derivative Credit Risk Valuation Adjustment Derivative Assets DerivativeCreditRiskValuationAdjustmentDerivativeAssets	0	USD
CY2020Q1	us-gaap	Derivative Credit Risk Valuation Adjustment Derivative Liabilities DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities	0	USD
CY2019Q1	us-gaap	Derivative Credit Risk Valuation Adjustment Derivative Liabilities DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities	0	USD
CY2019Q4	us-gaap	Derivative Credit Risk Valuation Adjustment Derivative Liabilities DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities	0	USD
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q1	dei	Entity File Number EntityFileNumber	0-11733
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	CITY HOLDING COMPANY
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WV
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	55-0619957
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	25 Gatewater Road,
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Charleston,
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	WV
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	25313
CY2020Q1	dei	City Area Code CityAreaCode	304
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	769-1100
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16148796	shares
CY2020Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	92365000	USD
CY2019Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	88658000	USD
CY2020Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	18271000	USD
CY2019Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	51486000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	110636000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	140144000	USD
CY2020Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	934113000	USD
CY2019Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	810106000	USD
CY2020Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	0	USD
CY2019Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	49036000	USD
CY2020Q1	chco	Other Investment Securities OtherInvestmentSecurities	26827000	USD
CY2019Q4	chco	Other Investment Securities OtherInvestmentSecurities	28490000	USD
CY2020Q1	us-gaap	Marketable Securities MarketableSecurities	960940000	USD
CY2019Q4	us-gaap	Marketable Securities MarketableSecurities	887632000	USD
CY2020Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	3613050000	USD
CY2019Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	3616099000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24393000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11589000	USD
CY2020Q1	us-gaap	Notes Receivable Net NotesReceivableNet	3588657000	USD
CY2019Q4	us-gaap	Notes Receivable Net NotesReceivableNet	3604510000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	116000000	USD
CY2019Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	115261000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	78948000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76965000	USD
CY2020Q1	us-gaap	Interest Receivable InterestReceivable	12570000	USD
CY2019Q4	us-gaap	Interest Receivable InterestReceivable	11569000	USD
CY2020Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2159000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6669000	USD
CY2020Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	119829000	USD
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	120241000	USD
CY2020Q1	us-gaap	Other Assets OtherAssets	98710000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	55765000	USD
CY2020Q1	us-gaap	Assets Assets	5088449000	USD
CY2019Q4	us-gaap	Assets Assets	5018756000	USD
CY2020Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	857501000	USD
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	805087000	USD
CY2020Q1	us-gaap	Demand Deposit Accounts DemandDepositAccounts	837966000	USD
CY2019Q4	us-gaap	Demand Deposit Accounts DemandDepositAccounts	896465000	USD
CY2020Q1	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	989609000	USD
CY2019Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	1009771000	USD
CY2020Q1	us-gaap	Time Deposits TimeDeposits	1366977000	USD
CY2019Q4	us-gaap	Time Deposits TimeDeposits	1364571000	USD
CY2020Q1	us-gaap	Deposits Deposits	4052053000	USD
CY2019Q4	us-gaap	Deposits Deposits	4075894000	USD
CY2020Q1	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	9900000	USD
CY2019Q4	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	0	USD
CY2020Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	224247000	USD
CY2019Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	211255000	USD
CY2020Q1	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	0	USD
CY2019Q4	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	4056000	USD
CY2020Q1	us-gaap	Other Liabilities OtherLiabilities	117021000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	69568000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	4403221000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	4360773000	USD
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	47619000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	47619000	USD
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	170096000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	170309000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	556718000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	539253000	USD
CY2020Q1	us-gaap	Treasury Stock Value TreasuryStockValue	116665000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	105038000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	33730000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	12110000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	6270000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	6270000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	27460000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5840000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	685228000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	657983000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5088449000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5018756000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	41335000	USD
CY2019Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	42279000	USD
CY2020Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	5871000	USD
CY2019Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	5689000	USD
CY2020Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	707000	USD
CY2019Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	779000	USD
CY2020Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	304000	USD
CY2019Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	186000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	48217000	USD
CY2019Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	48933000	USD
CY2020Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	7238000	USD
CY2019Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	7767000	USD
CY2020Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	464000	USD
CY2019Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	1052000	USD
CY2020Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	100000	USD
CY2019Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	48000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	7802000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	8867000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	40415000	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	40066000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	7972000	USD
CY2019Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-849000	USD
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	32443000	USD
CY2019Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	40915000	USD
CY2020Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	63000	USD
CY2019Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	88000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-2402000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	75000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	1676000	USD
CY2019Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	1016000	USD
CY2020Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	17837000	USD
CY2019Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0	USD
CY2020Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	1536000	USD
CY2019Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	814000	USD
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	33347000	USD
CY2019Q1	us-gaap	Noninterest Income NoninterestIncome	15925000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	15851000	USD
CY2019Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	15243000	USD
CY2020Q1	us-gaap	Occupancy Net OccupancyNet	2488000	USD
CY2019Q1	us-gaap	Occupancy Net OccupancyNet	2732000	USD
CY2020Q1	us-gaap	Equipment Expense EquipmentExpense	2429000	USD
CY2019Q1	us-gaap	Equipment Expense EquipmentExpense	2191000	USD
CY2020Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	0	USD
CY2019Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	291000	USD
CY2020Q1	us-gaap	Advertising Expense AdvertisingExpense	843000	USD
CY2019Q1	us-gaap	Advertising Expense AdvertisingExpense	869000	USD
CY2020Q1	chco	Bankcard Expenses BankcardExpenses	1435000	USD
CY2019Q1	chco	Bankcard Expenses BankcardExpenses	1182000	USD
CY2020Q1	us-gaap	Postage Expense PostageExpense	616000	USD
CY2019Q1	us-gaap	Postage Expense PostageExpense	624000	USD
CY2020Q1	us-gaap	Supplies Expense SuppliesExpense	394000	USD
CY2019Q1	us-gaap	Supplies Expense SuppliesExpense	386000	USD
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	601000	USD
CY2019Q1	us-gaap	Professional Fees ProfessionalFees	521000	USD
CY2020Q1	us-gaap	Communication Communication	511000	USD
CY2019Q1	us-gaap	Communication Communication	726000	USD
CY2020Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-198000	USD
CY2019Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-216000	USD
CY2020Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	0	USD
CY2019Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	250000	USD
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	4102000	USD
CY2019Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	4180000	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	29468000	USD
CY2019Q1	us-gaap	Noninterest Expense NoninterestExpense	29411000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	36322000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	27429000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7322000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5810000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	29000000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	21619000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16080000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16411000	shares
CY2020Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	21000	shares
CY2019Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	18000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16101000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16429000	shares
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.79
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.31
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.78
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.30
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	29000000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	21619000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	26714000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	11362000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	63000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	88000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax	1562000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	28213000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	11274000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	6593000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	2643000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	21620000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8631000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	50620000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30250000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	600764000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	21619000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8631000	USD
CY2019Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8739000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	803000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	252000	USD
CY2019Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4089000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	619241000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	657983000	USD
CY2020Q1	chco	New Accounting Pronouncement Effect Of Adoption Quantification NewAccountingPronouncementEffectOfAdoptionQuantification	-2335000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	29000000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	21620000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	9200000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1009000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	122000	USD
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	12971000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	685228000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	29000000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	21619000	USD
CY2020Q1	chco	Amortizationand Accretion Net AmortizationandAccretionNet	-422000	USD
CY2019Q1	chco	Amortizationand Accretion Net AmortizationandAccretionNet	455000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	7972000	USD
CY2019Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-849000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	1325000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	1209000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-824000	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1922000	USD
CY2020Q1	us-gaap	Pension Expense PensionExpense	181000	USD
CY2019Q1	us-gaap	Pension Expense PensionExpense	193000	USD
CY2020Q1	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	-2339000	USD
CY2019Q1	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	163000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1009000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	803000	USD
CY2020Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	121000	USD
CY2019Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	77000	USD
CY2020Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	1676000	USD
CY2019Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	1016000	USD
CY2020Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	2327000	USD
CY2019Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	4325000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	2229000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	5939000	USD
CY2020Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	77000	USD
CY2019Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	165000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1001000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1233000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5926000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4193000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	8937000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-57000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	40618000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20062000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-6442000	USD
CY2019Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-26920000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	94151000	USD
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	61432000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	26090000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	25062000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	20644000	USD
CY2019Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	15432000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	0	USD
CY2019Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	5484000	USD
CY2020Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1357000	USD
CY2019Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	9006000	USD
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	624000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	11715000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3329000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1576000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	119000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	30000	USD
CY2020Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	1412000	USD
CY2019Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	304000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	-440000	USD
CY2019Q1	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	0	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43066000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12933000	USD
CY2020Q1	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	52414000	USD
CY2019Q1	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	4514000	USD
CY2020Q1	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	-76100000	USD
CY2019Q1	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	63190000	USD
CY2020Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	22892000	USD
CY2019Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-67228000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4124000	USD
CY2019Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	12971000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4089000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	122000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	252000	USD
CY2020Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	9293000	USD
CY2019Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	8775000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-27060000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12136000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-29508000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	20859000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140144000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122991000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110636000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	143850000	USD
CY2020Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2020Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	700000	USD
CY2020Q1	chco	Deposits Sold DepositsSold	25700000	USD
CY2020Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	3618825000	USD
CY2019Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	3616099000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	17349000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11589000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7380000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	6669000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	655648000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	657983000	USD
CY2020Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	889940000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	46950000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2777000	USD
CY2020Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	934113000	USD
CY2019Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	794117000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	18210000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2221000	USD
CY2019Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	810106000	USD
CY2019Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	49036000	USD
CY2019Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	1562000	USD
CY2019Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	0	USD
CY2019Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	50598000	USD
CY2020Q1	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	16600000	USD
CY2019Q4	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	15900000	USD
CY2020Q1	chco	Non Governmental Issues Exceeding10 Shareholders Equity Threshold NonGovernmentalIssuesExceeding10ShareholdersEquityThreshold	0	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	103127000	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1606000	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	8500000	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1171000	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	111627000	USD
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	2777000	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	138967000	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1637000	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	36185000	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	584000	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	175152000	USD
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	2221000	USD
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	0	USD
CY2020Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Additional Credit Losses OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsAdditionalCreditLosses	0	USD
CY2020Q1	chco	Percent Of Average Daily Trading Volume PercentOfAverageDailyTradingVolume	0.002
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2091000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2108000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	14955000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	15386000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	235144000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	248975000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	635509000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	665403000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	887699000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	931872000	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	134000	USD
CY2019Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	89000	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	71000	USD
CY2019Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1000	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	63000	USD
CY2019Q1	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	88000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	24000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	143000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	2426000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	68000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-2402000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	75000	USD
CY2020Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	3613050000	USD
CY2019Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	3616099000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24393000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11589000	USD
CY2020Q1	us-gaap	Notes Receivable Net NotesReceivableNet	3588657000	USD
CY2019Q4	us-gaap	Notes Receivable Net NotesReceivableNet	3604510000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11589000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1746000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	818000	USD
CY2020Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	7972000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24393000	USD
CY2018Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	15966000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1229000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	758000	USD
CY2019Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-849000	USD
CY2019Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14646000	USD
CY2020Q1	chco	Threshold Periodfor Discontinuanceof Interest Accrual ThresholdPeriodforDiscontinuanceofInterestAccrual	P90D
CY2020Q1	us-gaap	Financing Receivable Nonaccrual No Allowance FinancingReceivableNonaccrualNoAllowance	3207000	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	8833000	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	26000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	11490000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	267000	USD
CY2020Q1	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	100000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	4047000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	4073000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	2644000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	2644000	USD
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	87000	USD
CY2019Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	7139000	USD
CY2019Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	36000	USD
CY2019Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	2985000	USD
CY2019Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	30000	USD
CY2019Q1	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	100000	USD
CY2020Q1	us-gaap	Financing Receivable Threshold Period Past Due FinancingReceivableThresholdPeriodPastDue	P30D
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	9981000	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	3603069000	USD
CY2020Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	3613050000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	11396000	USD
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	3604703000	USD
CY2019Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	3616099000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	29054000	USD
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	29630000	USD
CY2020Q1	chco	Financing Receivable Troubled Debt Restructuring Allowance For Credit Losses FinancingReceivableTroubledDebtRestructuringAllowanceForCreditLosses	700000	USD
CY2019Q4	chco	Financing Receivable Troubled Debt Restructuring Allowance For Credit Losses FinancingReceivableTroubledDebtRestructuringAllowanceForCreditLosses	800000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	11	contract
CY2020Q1	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	877000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	875000	USD
CY2019Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	28	contract
CY2019Q1	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	1798000	USD
CY2019Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	1798000	USD
CY2020Q1	chco	Financing Receivables Impaired Troubled Debt Restructuring Provision For Credit Losses FinancingReceivablesImpairedTroubledDebtRestructuringProvisionForCreditLosses	100000	USD
CY2020Q1	us-gaap	Financing Receivables Impaired Troubled Debt Restructuring Write Down FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown	100000	USD
CY2019	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	1	contract
CY2019	us-gaap	Financing Receivable Modifications Subsequent Default Recorded Investment1 FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1	3000000.0	USD
CY2019	us-gaap	Financing Receivables Impaired Troubled Debt Restructuring Write Down FinancingReceivablesImpairedTroubledDebtRestructuringWriteDown	700000	USD
CY2020Q1	us-gaap	Collateral Already Posted Aggregate Fair Value CollateralAlreadyPostedAggregateFairValue	65400000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	112000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	174000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	203000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	266000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-272000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-285000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	181000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	193000	USD
CY2020Q1	chco	Combined Federal And State Income Tax Rate CombinedFederalAndStateIncomeTaxRate	0.23
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	29000000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	21619000	USD
CY2020Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-263000	USD
CY2019Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-186000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	28737000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	21433000	USD
CY2020Q1	us-gaap	Distributed Earnings DistributedEarnings	9117000	USD
CY2019Q1	us-gaap	Distributed Earnings DistributedEarnings	8661000	USD
CY2020Q1	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	19620000	USD
CY2019Q1	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	12772000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	28737000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	21433000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16080000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16411000	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	21000	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16101000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16429000	shares
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.79
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.31
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.78
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.30
CY2020Q1	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	0	USD
CY2020Q1	us-gaap	Derivative Credit Risk Valuation Adjustment Derivative Assets DerivativeCreditRiskValuationAdjustmentDerivativeAssets	0	USD

Files In Submission

Name	View Source	Status
0000726854-20-000082-index-headers.html	Edgar Link	pending
0000726854-20-000082-index.html	Edgar Link	pending
0000726854-20-000082.txt	Edgar Link	pending
0000726854-20-000082-xbrl.zip	Edgar Link	pending
chco-20200331.htm	Edgar Link	pending
chco-20200331.xsd	Edgar Link	pending
chco-20200331_cal.xml	Edgar Link	unprocessable
chco-20200331_def.xml	Edgar Link	unprocessable
chco-20200331_g1.jpg	Edgar Link	pending
chco-20200331_htm.xml	Edgar Link	completed
chco-20200331_lab.xml	Edgar Link	unprocessable
chco-20200331_pre.xml	Edgar Link	unprocessable
exhibit31a03-31x2020.htm	Edgar Link	pending
exhibit31b03-31x2020.htm	Edgar Link	pending
exhibit32a03-31x2020.htm	Edgar Link	pending
exhibit32b03-31x2020.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHCO
City Holding Co Stock $chco

2020 Q1 Form 10-Q Financial Statement

#000072685420000082 Filed on May 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHCO City Holding Co Stock $chco

2020 Q1 Form 10-Q Financial Statement

#000072685420000082 Filed on May 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHCO
City Holding Co Stock $chco